These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 23740642)

  • 21. A comparison of olanzapine with haloperidol in cannabis-induced psychotic disorder: a double-blind randomized controlled trial.
    Berk M; Brook S; Trandafir AI
    Int Clin Psychopharmacol; 1999 May; 14(3):177-80. PubMed ID: 10435771
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dibenzodiazepine derivative quetiapine- and olanzapine-induced chronic interstitial nephritis.
    He L; Peng Y; Fu X; Chen X; Liu H
    Ren Fail; 2013; 35(5):657-9. PubMed ID: 23560804
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Olanzapine and benztropine as a cause of ischemic colitis in a 27-year-old man.
    Park SJ; Gunn N; Harrison SA
    J Clin Gastroenterol; 2012 Jul; 46(6):515-7. PubMed ID: 22011585
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Safety of olanzapine use in adolescents.
    Schulz C; Haight RJ
    Expert Opin Drug Saf; 2013 Sep; 12(5):777-82. PubMed ID: 23876012
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effects of antipsychotic drug treatment on prolactin concentrations in elderly patients.
    Kinon BJ; Stauffer VL; McGuire HC; Kaiser CJ; Dickson RA; Kennedy JS
    J Am Med Dir Assoc; 2003; 4(4):189-94. PubMed ID: 12837139
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Disturbed glucose metabolism among patients taking olanzapine and typical antipsychotics.
    Dunlop BW; Sternberg M; Phillips LS; Andersen J; Duncan E
    Psychopharmacol Bull; 2003; 37(3):99-117. PubMed ID: 14608243
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Olanzapine and acute urinary retention in two geriatric patients.
    Cohen R; Wilkins KM; Ostroff R; Tampi RR
    Am J Geriatr Pharmacother; 2007 Sep; 5(3):241-6. PubMed ID: 17996664
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risperidone treatment in elderly patients with dementia: relative risk of cerebrovascular events versus other antipsychotics.
    Finkel S; Kozma C; Long S; Greenspan A; Mahmoud R; Baser O; Engelhart L
    Int Psychogeriatr; 2005 Dec; 17(4):617-29. PubMed ID: 16202186
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antipsychotic exposure and type 2 diabetes among patients with schizophrenia: a matched case-control study of California Medicaid claims.
    Lambert BL; Chou CH; Chang KY; Tafesse E; Carson W
    Pharmacoepidemiol Drug Saf; 2005 Jun; 14(6):417-25. PubMed ID: 15786516
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Supersensitivity psychosis in patients with schizophrenia after sudden olanzapine withdrawal.
    Llorca PM; Vaiva G; Lancon C
    Can J Psychiatry; 2001 Feb; 46(1):87-8. PubMed ID: 11221497
    [No Abstract]   [Full Text] [Related]  

  • 31. Dose-Dependent Facial Edema Secondary to Olanzapine in a Medium-Long Stay Psychiatry Ward: Case Report and Review of Cases.
    Tascon-Cervera JJ; Torres-Tejera LM; Herrera-Muñoz M; Dorta-González JF; Alcántara-Gutiérrez M; Morera-Fumero AL
    J Clin Psychopharmacol; 2022 Mar-Apr 01; 42(2):210-211. PubMed ID: 35230049
    [No Abstract]   [Full Text] [Related]  

  • 32. Prolongation of clozapine-induced leukopenia with olanzapine treatment.
    Sayin A; Cosar B
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Jul; 30(5):958-9. PubMed ID: 16631295
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Olanzapine long-acting post-injection syndrome: a case report and brief review].
    Duran-Sindreu SF; Grasa-Bello E; Corripio-Collado I; Sauras-Quetcuti RB; Keymer-Gausset A; Roldán-Bejarano A; Alonso-Solís A; Figueras-Vilalta M; Álvarez-Martínez E
    Actas Esp Psiquiatr; 2013; 41(1):60-2. PubMed ID: 23440537
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Olanzapine-induced leucopenia and neutropenia.
    Stergiou V; Bozikas VP; Garyfallos G; Nikolaidis N; Lavrentiadis G; Fokas K
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jul; 29(6):992-4. PubMed ID: 15950350
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Drug safety evaluation of olanzapine pamoate.
    Schöttle D; Kuhnigk O; Naber D
    Expert Opin Drug Saf; 2013 Nov; 12(6):897-903. PubMed ID: 24024627
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Atypical antipsychotics and risk of cerebrovascular accidents.
    Herrmann N; Mamdani M; Lanctôt KL
    Am J Psychiatry; 2004 Jun; 161(6):1113-5. PubMed ID: 15169702
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Olanzapine-induced neuroleptic malignant syndrome in a patient with paranoid schizophrenia.
    Srivastava A; Borkar HA; Chandak S
    Psychiatry Clin Neurosci; 2009 Feb; 63(1):119-21. PubMed ID: 19067992
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Use of atypical antipsychotics in Charles Perrens psychiatric hospital (Bordeaux) analysis of prescribing practices for Amisulpride, Clozapine, Olanzapine and Risperidone].
    Bret P; Bonnet F; Bret MC; Jaffré A
    Encephale; 2002; 28(4):329-42. PubMed ID: 12232542
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Scalp necrosis in giant cell arteritis after initiation of therapeutic corticosteroids.
    Brick KE; Cook-Norris RH; Wetter DA; Warrington KJ
    J Am Acad Dermatol; 2010 Aug; 63(2):343-4. PubMed ID: 20633804
    [No Abstract]   [Full Text] [Related]  

  • 40. Restless legs syndrome and periodic limb movements during sleep probably associated with olanzapine.
    Kang SG; Lee HJ; Kim L
    J Psychopharmacol; 2009 Jul; 23(5):597-601. PubMed ID: 18562412
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.